Potassium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB14500 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 75 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hypertensive disorder | KG + DL |
| 2 | pulmonary hypertension with unclear multifactorial mechanism | KG + DL |
| 3 | pulmonary hypertension owing to lung disease and/or hypoxia | KG + DL |
| 4 | malignant renovascular hypertension | KG + DL |
| 5 | malignant hypertensive renal disease | KG + DL |
| 6 | Braddock syndrome | KG + DL |
| 7 | chronic pulmonary heart disease | KG + DL |
| 8 | congestive heart failure | KG + DL |
| 9 | alopecia | KG + DL |
| 10 | congenital hypotrichosis milia | KG + DL |
| 11 | diffuse alopecia areata | KG + DL |
| 12 | hypotrichosis simplex of the scalp | KG + DL |
| 13 | acute pulmonary heart disease | KG + DL |
| 14 | gout | KG + DL |
| 15 | Raynaud disease | KG + DL |
| 16 | potassium deficiency disease | KG + DL |
| 17 | open-angle glaucoma | KG + DL |
| 18 | primary hereditary glaucoma | KG + DL |
| 19 | chronic renal failure syndrome | KG + DL |
| 20 | rheumatoid arthritis | KG + DL |
| 21 | pulmonary hypertension | KG + DL |
| 22 | chronic kidney disease | KG + DL |
| 23 | end stage renal failure | KG + DL |
| 24 | kyphoscoliotic heart disease | KG + DL |
| 25 | myocardial infarction | KG + DL |
| 26 | headache disorder | KG + DL |
| 27 | cor pulmonale | KG + DL |
| 28 | posterolateral myocardial infarction | KG + DL |
| 29 | posteroinferior myocardial infarction | KG + DL |
| 30 | diabetic nephropathy | KG + DL |
| 31 | trigeminal autonomic cephalalgia | KG + DL |
| 32 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 33 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 34 | septal myocardial infarction | KG + DL |
| 35 | osteoarthritis susceptibility | KG + DL |
| 36 | phaeochromocytoma | KG + DL |
| 37 | hemoglobinopathy | KG + DL |
| 38 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 39 | bronchitis | KG + DL |
| 40 | gastroduodenitis | KG + DL |
| 41 | osteoarthritis | KG + DL |
| 42 | peptic ulcer disease | KG + DL |
| 43 | brachydactyly-syndactyly syndrome | KG + DL |
| 44 | peripheral vascular disease | KG + DL |
| 45 | ischemia reperfusion injury | KG + DL |
| 46 | hepatic porphyria | KG + DL |
| 47 | beta-thalassemia with other manifestations | KG + DL |
| 48 | heart failure | KG + DL |
| 49 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 50 | pyruvate kinase deficiency of red cells | KG + DL |
(Showing top 50 of 75 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.